Should we also evaluate SET together with CIP2A for the treatment with second-generation tyrosine kinase inhibitors in chronic myeloid leukemia?

Cristóbal, I; Manso, R; González-Alonso, P; Rojo, F; García-Foncillas, J

Cristóbal, I; Manso, R; González-Alonso, P; Rojo, F; García-Foncillas, J.

Affiliation

Cristóbal I; Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jiménez Diaz, UAM, University Hospital 'Fundación Jiménez Diaz', Madrid, Spain.
Manso R; Pathology Department, IIS-Fundación Jiménez Diaz, Madrid, Spain.
González-Alonso P; Pathology Department, IIS-Fundación Jiménez Diaz, Madrid, Spain.
Rojo F; Pathology Department, IIS-Fundación Jiménez Diaz, Madrid, Spain.
García-Foncillas J; Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jiménez Diaz, UAM, University Hospital 'Fundación Jiménez Diaz', Madrid, Spain.

Leukemia ; 29(10): 2117, 2015 Oct.

Article in En | MEDLINE | ID: mdl-26283451

Subject(s)

Histone Chaperones/antagonists & inhibitors; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/enzymology; Membrane Proteins/antagonists & inhibitors; Protein Kinase Inhibitors/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Transcription Factors/antagonists & inhibitors; Autoantigens; DNA-Binding Proteins; Evaluation Studies as Topic; Humans; Intracellular Signaling Peptides and Proteins; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Protein Kinase Inhibitors / Histone Chaperones / Membrane Proteins Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google